Re: TSHI

Dear Jeffrey;

Thank you for your invitation to twitter. However I ask you to consider your support for my developing this amazing TSH1.

In fact I do not like Twitter. My science is not based on peoples desire, my science is based on fact.

Do you know any medicine, drugs can recover the cognitive ability of patient with an advanced stage to active, even normal cognition?

Many clinical trials for Alzheimer's patients with earlier, even middle stage are all failed. And scientist said the clinical trial for the patients with severe or middle stage are too late to recover their cognition, because their neurons are almost dead. Is it a true?

I am now happy to open the non-confidential data to you. You may be surprised at my data. Because my TSH1 can induce the strong recovery process of the sever advanced stage of Alzheimer's disease patients. Especially TSH1 can induce the hippocampal volume recovery in No 1 patient.

Now I sincerely request you to support my TSH1 developing. As you know, Alzheimer's disease is known as a non-cure disease, non-treatable disease, but now TSH1 can cure and recover AD cognitive impairment.

Sincerely yours
Tohru Hasegawa, Ph.D and Prof.

EFTA00703254

Dear Mr. Hasegawa,

Thank you very much for reaching us. Jeffrey is interested in your work and would like you to email me an updated and detailed abstract of I) How your therapy works and 2) its application and success thus far. Please also send me links to any websites of yours.

I have reviewed the attachments that you sent. The first one, I could not open, the 2nd is not detailed enough and the 3rd, the brain scan is not backed with any explanation.

We look forward to reading more about your important work.

Thank you and best regards,

EFTA00703253

Christina

Dear

I am looking forward to hearing from you soon. It past almost one month. My project is going to collaborate with one company. As I told you, my TSH1 is now producing as a healthy food. In Japan, the healthy food is not difficult for selling, but one limitation should be done. That is, we cannot advertise its efficacy. So I should have many seminars to open my research results which is independent from this healthy food. That is why I need your supports.

In future, perhaps in this year end, my TSH1 is opened in your USA. That is why I need your support.

So please let me know what is going on in your reviewing.

Sincerely yours

Tohru

Dear Christina;
I am answering your questions.

(1) TSH1 is name of our brain food. This componenet is ferulic acid. But I am sorry I can't open the other important component of TSH1 at present.

(2) Since my research made clear that the pathogen of Alzheimer's disease was homocysteic acid in blood, then first my TSH1 first blocks the homocysteic acid in brain at NMDA receptor. Second my TSH1 decopomses homocysteic acid, especially sulfide group of homocysteic acid in blood. My TSH1 stimulates the urinary excretion of homocysteic acid in blood. Alzheimer's and late onset of Alzheimer's disease are same pathogen. You may question that then why late onset of Alzheimer's and early onset of Alzheimer's disease are different in onset. That is why amyloid protein is involved in onset. Early onset of Alzheimer's disease shows high level of amyloid protein, which increases homocysteic acid toxicity. Then lower level of homocysteic acid induced the onset of Alzheimer's. It is important that amyloid protein only is not a pathogen of Alzheimer's disease.

(3) TSH1 is orally administrated. 2g of TSH1 was administrated.

(4) Basically ferulic acid is already known in Japan as a potent therapy effect of Alzheimer's disease. However ferulic acid efficacy is rather small. That is 40% of ferulic acid amnistrated patients showed the recovery. My TSH1 clinical trail was Phase 2 . Phase 1 was already shown no toxicity of TSH1.

(5) !00% of all TSH1 adminstrated patients showed the cognitive recovery

EFTA00703251

If you have still some questions, I am very happy to answer your questions.

Sincerely yours

Tohru

Dear Mr. Hasegawa,

I hope that you are well. Jeffrey Epstein would be delighted to review your work but as I mentioned he needs more documentation from you. Namely:

1. What is TSH1? What are some of the basic components?

2. How does it work to combat Alzheimer's and/or Late Onset Alzheimer's?

3. How is TSH1 administered? Orally, intravenously? What are the doses?

4. What has been your trial base/ makeup?

5. What have been your results?

Please send me as much documentation on the above as possible and I will forward it to Jeffrey to review.

My best regards,

EFTA00703252